CLICK “CONTINUE” AT THE BOTTOM OF THE PAGE TO COMPLETE YOUR REGISTRATION TO JOIN US IN NEW ORLEANS, LA.

CAN’T MAKE IT TO NEW ORLEANS? CLICK “CONTINUE” AT THE BOTTOM OF THE PAGE AND SELECT THE LIVE STREAMING OPTION TO PARTICIPATE VIRTUALLY.

Friday, December 11, 2026
Registration and Dinner: 7:00 PM – 7:30 PM CT
Symposium: 7:30 PM – 9:00 PM CT
Location: New Orleans Ernest N. Morial Convention Center
900 Convention Center Blvd
Meeting Room: 343-345 (3rd Floor)
 

Faculty 

Stephen Hunger, MD (Chair)
Audrey E. Evans Endowed Chair in Pediatric Oncology
Chief, Division of Pediatric Oncology
Director, Center for Childhood Cancer Research
Children’s Hospital of Philadelphia
Philadelphia, PA

Seth Karol, MD, MSCI
Associate Member, Leukemia/Lymphoma Division
Department of Oncology
St. Jude Children’s Research Hospital
Memphis, TN

Marlise R. Luskin, MD, MSCE
Division of Leukemia
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Target Audience 

This activity has been designed to meet the educational needs of hematology/oncology physicians and fellows, pathologists, and oncology advanced practice providers. It may also benefit clinical and oncology pharmacists, oncology nurses, and other HCPs who manage patients with acute lymphoblastic leukemia (ALL).
 

Educational Provider

This activity is provided by Paradigm Medical Communications, LLC.  

 

Supporter Acknowledgment 

This activity is supported by an educational grant from Servier Pharmaceuticals, LLC.   
 

Program Overview

Join us for an exciting live, in-person symposium exploring the rapidly evolving treatment landscape for adolescents and young adults (AYAs) with ALL. Learn how frontline pediatric-inspired regimens, asparaginase-based therapy, novel immunotherapies, and CAR T-cell treatments are transforming outcomes for this unique patient population. Through expert-led discussions and real-world clinical insights, attendees will gain practical strategies for incorporating emerging therapies, navigating treatment complexities, and addressing the distinctive psychosocial challenges faced by AYAs with ALL to deliver optimal, personalized care.
 

Learning Objectives

Upon completion of this activity, participants should be able to:

• Review current evidence-based treatment recommendations for AYAs with ALL based on practice setting and other clinical factors 
• Create a treatment plan for AYAs newly diagnosed with Ph-negative ALL based on evidence-based guidelines 
• Evaluate how new immunotherapies and other novel agents can be integrated into the treatment plan for an AYA with Ph-negative ALL
• Describe unique psychosocial issues of AYAs with ALL

Physician Accreditation Statement

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Physician Credit Designation Statement

Paradigm Medical Communications, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
 

PA Continuing Education 

PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
 

Nurse Practitioner Continuing Education 

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Disclosure of Relevant Financial Relationships 

In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months.  Disclosure information about relevant financial relationships with ineligible companies (if any) for anyone contributing to content development will be included in materials distributed at the time of the activity. 
 

CME Inquires

For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com.
 

Fee Information

There is no fee required for participation in this activity.
 

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (physical, dietary, etc).  Please contact Paradigm prior to the event at medicaleducation@paradigmmc.org.

Click the "Register Now" button. Once registered, you will receive an email confirmation with the event details.

© 2026 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.